Compare Stocks: HQH, FHI, LAZ, and OTF

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FHI Federated Hermes	$63.13 -0.2%	$58.57	$46.66 ▼ $67.20	$4.79B	0.65	575,426 shs	368,666 shs
HQH abrdn Healthcare Investors	$23.02 +0.8%	$20.94	$15.57 ▼ $23.15	$1.32B	0.78	274,428 shs	228,437 shs
LAZ Lazard	$44.09 +1.8%	$43.32	$38.67 ▼ $58.75	$4.89B	1.43	1.82 million shs	1.76 million shs
OTF Blue Owl Technology Finance	$11.73 +3.5%	$10.55	$9.75 ▼ $15.82	$5.36B	-0.86	2.56 million shs	3.94 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FHI Federated Hermes	0.00%	+4.84%	+7.38%	+13.01%	+22.76%
HQH abrdn Healthcare Investors	0.00%	+5.86%	+4.71%	+14.87%	+47.05%
LAZ Lazard	0.00%	+3.96%	+5.57%	-8.21%	-14.77%
OTF Blue Owl Technology Finance	0.00%	+17.51%	+15.42%	+7.19%	+1,173,199,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FHI Federated Hermes	$63.13 -0.2%	$58.57	$46.66 ▼ $67.20	$4.79B	0.65	575,426 shs	368,666 shs
HQH abrdn Healthcare Investors	$23.02 +0.8%	$20.94	$15.57 ▼ $23.15	$1.32B	0.78	274,428 shs	228,437 shs
LAZ Lazard	$44.09 +1.8%	$43.32	$38.67 ▼ $58.75	$4.89B	1.43	1.82 million shs	1.76 million shs
OTF Blue Owl Technology Finance	$11.73 +3.5%	$10.55	$9.75 ▼ $15.82	$5.36B	-0.86	2.56 million shs	3.94 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FHI Federated Hermes	0.00%	+4.84%	+7.38%	+13.01%	+22.76%
HQH abrdn Healthcare Investors	0.00%	+5.86%	+4.71%	+14.87%	+47.05%
LAZ Lazard	0.00%	+3.96%	+5.57%	-8.21%	-14.77%
OTF Blue Owl Technology Finance	0.00%	+17.51%	+15.42%	+7.19%	+1,173,199,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FHI Federated Hermes	2.13	Hold	$56.20	-10.98% Downside
HQH abrdn Healthcare Investors	0.00	N/A	N/A	N/A
LAZ Lazard	2.09	Hold	$50.38	14.27% Upside
OTF Blue Owl Technology Finance	2.57	Moderate Buy	$13.60	15.92% Upside

Current Analyst Ratings Breakdown

Latest HQH, FHI, LAZ, and OTF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/7/2026	OTF Blue Owl Technology Finance	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/7/2026	OTF Blue Owl Technology Finance	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$16.00 ➝ $17.00
8/4/2026	LAZ Lazard	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/3/2026	FHI Federated Hermes	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$58.00
7/31/2026	FHI Federated Hermes	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B) ➝ Buy (B+)
7/29/2026	LAZ Lazard	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
7/24/2026	LAZ Lazard	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$44.00
7/24/2026	LAZ Lazard	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
7/24/2026	LAZ Lazard	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Perform	$44.00 ➝ $42.00
7/23/2026	LAZ Lazard	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell
7/17/2026	FHI Federated Hermes	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B)

(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FHI Federated Hermes	$1.93B	2.48	$5.41 per share	11.66	$16.50 per share	3.83
HQH abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A	N/A
LAZ Lazard	$3.10B	1.57	$6.79 per share	6.49	$8.18 per share	5.39
OTF Blue Owl Technology Finance	$1.15B	4.69	$1.04 per share	11.26	$16.46 per share	0.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FHI Federated Hermes	$403.30M	$5.38	11.73	10.87	1.48	21.30%	34.03%	18.54%	N/A
HQH abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LAZ Lazard	$236.83M	$2.04	21.61	10.99	0.93	6.95%	23.58%	4.63%	10/22/2026 (Estimated)
OTF Blue Owl Technology Finance	$720.37M	$0.80	14.67	8.69	N/A	28.69%	7.17%	3.86%	N/A

Latest HQH, FHI, LAZ, and OTF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	OTF Blue Owl Technology Finance	$0.31	$0.33	+$0.02	$0.33	N/A	$279.54 million
7/30/2026	Q2 2026	FHI Federated Hermes	$1.19	$1.38	+$0.19	$1.38	$488.34 million	$502.78 million
7/24/2026	Q2 2026	LAZ Lazard	$0.3382	$0.12	-$0.2182	$0.03	$736.29 million	$786.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FHI Federated Hermes	$1.52	2.41%	-8.56%	28.25%	4 Years
HQH abrdn Healthcare Investors	$2.32	10.08%	N/A	N/A	N/A
LAZ Lazard	$2.00	4.54%	+1.24%	98.04%	N/A
OTF Blue Owl Technology Finance	$1.40	11.93%	N/A	175.00%	N/A

Latest HQH, FHI, LAZ, and OTF Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	OTF Blue Owl Technology Finance	quarterly	$0.35	13.49%	9/30/2026	9/30/2026	10/15/2026
7/30/2026	FHI Federated Hermes	quarterly	$0.38	2.41%	8/7/2026	8/7/2026	8/14/2026
7/22/2026	LAZ Lazard	quarterly	$0.50	4.62%	8/3/2026	8/3/2026	8/14/2026
5/11/2026	HQH abrdn Healthcare Investors	quarterly	$0.61	12.46%	5/21/2026	5/21/2026	6/30/2026
5/11/2026	HQH abrdn Healthcare Investors	quarterly	$0.61	12.17%	5/21/2026	5/21/2026	5/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FHI Federated Hermes	0.28	2.59	2.73
HQH abrdn Healthcare Investors	N/A	N/A	N/A
LAZ Lazard	1.87	2.84	2.84
OTF Blue Owl Technology Finance	N/A	0.05	0.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FHI Federated Hermes	75.94%
HQH abrdn Healthcare Investors	32.60%
LAZ Lazard	54.80%
OTF Blue Owl Technology Finance	N/A

Insider Ownership

Company	Insider Ownership
FHI Federated Hermes	4.20%
HQH abrdn Healthcare Investors	7.30%
LAZ Lazard	0.95%
OTF Blue Owl Technology Finance	0.05%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FHI Federated Hermes	2,091	75.91 million	72.73 million	Not Optionable
HQH abrdn Healthcare Investors	147,000	57.19 million	53.02 million	Not Optionable
LAZ Lazard	3,309	110.55 million	109.50 million	Optionable
OTF Blue Owl Technology Finance	N/A	458.18 million	457.96 million	N/A

HQH, FHI, LAZ, and OTF Headlines

Recent News About These Companies

Blue Owl Technology Finance Q2 Earnings Call Highlights

August 8 at 8:02 PM | marketbeat.com

Blue Owl Technology Finance (NYSE:OTF) Price Target Raised to $17.00

August 7 at 11:35 AM | marketbeat.com

Blue Owl Technology Finance Corp. 2026 Q2 - Results - Earnings Call Presentation

August 6 at 2:31 PM | seekingalpha.com

Blue Owl Technology Finance Corp. (NYSE:OTF) Receives $13.40 Consensus Price Target from Analysts

August 6 at 3:30 AM | americanbankingnews.com

Blue Owl Technology Finance (OTF) Misses Q2 Earnings and Revenue Estimates

August 5, 2026 | zacks.com

Blue Owl Tech: Q2 Earnings Snapshot

August 5, 2026 | chron.com

Blue Owl Technology Finance Corp. Announces June 30, 2026 Financial Results

August 5, 2026 | prnewswire.com

Blue Owl Technology Finance (NYSE:OTF) Reaches New 12-Month Low - Here's What Happened

August 2, 2026 | americanbankingnews.com

Blue Owl Technology Finance Corp. (NYSE:OTF) Given Average Rating of "Moderate Buy" by Brokerages

August 1, 2026 | marketbeat.com

Blue Owl Technology Finance (NYSE:OTF) Hits New 1-Year Low - Here's What Happened

July 31, 2026 | marketbeat.com

Pine Ridge Advisers LLC Buys 511,368 Shares of Blue Owl Technology Finance Corp. $OTF

July 29, 2026 | marketbeat.com

Rivernorth Capital Management LLC Boosts Position in Blue Owl Technology Finance Corp. $OTF

July 29, 2026 | marketbeat.com

California State Teachers Retirement System Invests $250.56 Million in Blue Owl Technology Finance Corp. $OTF

July 29, 2026 | marketbeat.com

OMERS ADMINISTRATION Corp Grows Holdings in Blue Owl Technology Finance Corp. $OTF

July 27, 2026 | marketbeat.com

Callodine Capital Management LP Acquires New Position in Blue Owl Technology Finance Corp. $OTF

July 26, 2026 | marketbeat.com

Blue Owl Technology Finance (NYSE:OTF) Sets New 12-Month Low - Here's What Happened

July 23, 2026 | marketbeat.com

Blue Owl Technology Finance: A Deep Discount To Book, But The Marks Are On Trial

July 21, 2026 | seekingalpha.com

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Blue Owl Technology Finance Corp.

July 21, 2026 | globenewswire.com

Blue Owl Technology Finance Corp. (OTF) Investigation: Johnson Fistel Encourages Investors to Contact the Firm

July 20, 2026 | globenewswire.com

Sanctuary Advisors LLC Boosts Stake in Blue Owl Technology Finance Corp. $OTF

July 20, 2026 | marketbeat.com

Blue Owl Technology Finance: The Current Price Implies Half The Portfolio Defaults, Strong Buy

July 19, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQH, FHI, LAZ, and OTF Company Descriptions

Federated Hermes NYSE:FHI

$63.13 -0.12 (-0.19%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$63.16 +0.03 (+0.04%)

As of 08/7/2026 07:34 PM Eastern

Federated Hermes, Inc. is a publicly owned investment manager. Through its subsidiaries, the firm provides its services to individuals, including high net worth individuals, banking or thrift institutions, investment companies, pension and profit sharing plans, pooled investment vehicles, charitable organizations, state or municipal government entities, and registered investment advisors. Through its subsidiaries, it manages separate client-focused equity, fixed income, balanced and money market mutual funds along with separate client-focused equity, fixed income, money market, and balanced portfolios. Through its subsidiaries, the firm invests in the public equity and fixed income markets across the globe. It invests in growth and value stocks of small-cap, mid-cap, and large-cap companies. The firm makes its fixed income investments in ultra-short, short-term, and intermediate-term mortgage-backed, U.S. Government, U.S. corporate, high yield, and municipal securities. It employs both fundamental and quantitative analysis to make its equity investments. Federated Hermes, Inc. was founded in 1955 and is based in Pittsburgh, Pennsylvania with additional offices in New York City and London, United Kingdom.

abrdn Healthcare Investors NYSE:HQH

$23.02 +0.19 (+0.83%)

Closing price 08/7/2026 03:58 PM Eastern

Extended Trading

$23.05 +0.03 (+0.13%)

As of 08/7/2026 07:34 PM Eastern

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Lazard NYSE:LAZ

$44.08 +0.77 (+1.77%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$44.20 +0.12 (+0.26%)

As of 08/7/2026 07:34 PM Eastern

Lazard, Inc., together with its subsidiaries, operates as a financial advisory and asset management firm in North and South America, Europe, the Middle East, Asia, and Australia. It operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical advisory, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services. This segment offers its services to corporate, partnership, institutional, government, sovereign, and individual clients to various industry areas, including consumers, financial institutions, healthcare and life sciences, industrials, power and energy/infrastructure, real estate, technology, telecommunication, and media and entertainment. The Asset Management segment offers a range of investment solutions; investment and wealth management services in equity and fixed income strategies; asset allocation strategies; and alternative investments and private equity funds to corporations, public funds, sovereign entities, endowments and foundations, labor funds, financial intermediaries, and private clients. Lazard, Inc. was incorporated in 1848 and is headquartered in New York, New York.

Blue Owl Technology Finance NYSE:OTF

$11.73 +0.40 (+3.55%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$11.39 -0.35 (-2.95%)

As of 08/7/2026 08:00 PM Eastern

Blue Owl Technology Finance Corp. is a specialty finance company focused on making debt and equity investments to U.S. technology-related companies, with a strategic focus on software. Blue Owl Technology Finance Corp. is based in NEW YORK.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HQH, FHI, LAZ, and OTF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HQH, FHI, LAZ, and OTF Earnings

Compare Dividends

Latest HQH, FHI, LAZ, and OTF Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HQH, FHI, LAZ, and OTF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQH, FHI, LAZ, and OTF Company Descriptions

Federated Hermes NYSE:FHI

abrdn Healthcare Investors NYSE:HQH

Lazard NYSE:LAZ

Blue Owl Technology Finance NYSE:OTF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HQH, FHI, LAZ, and OTF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HQH, FHI, LAZ, and OTF Earnings

Compare Dividends

Latest HQH, FHI, LAZ, and OTF Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HQH, FHI, LAZ, and OTF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQH, FHI, LAZ, and OTF Company Descriptions

Federated Hermes NYSE:FHI

abrdn Healthcare Investors NYSE:HQH

Lazard NYSE:LAZ

Blue Owl Technology Finance NYSE:OTF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools